At Eko, we’re dedicated to providing healthcare professionals with industry leading digital tools to hear and understand their patients’ hearts and lungs. With our platform, clinicians can detect cardiopulmonary disease with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.
With over $165M in funding from partners like 3M and the Mayo Clinic, Eko has become one of the fastest growing digital health companies, doubling our customer base in the last year to over 500,000 clinicians across 4,000 U.S. hospitals. We’ve built a tremendously talented, diverse, and mission driven team and are proud to be certified as a Great Place to Work®. Together we are committed to investing in each other and our mission to ensure all patients have access to high quality care.
The Head of Market Access and Reimbursement will lead efforts to achieve favorable coverage and reimbursement for Eko’s disease detection technology in the United States.
This is a hands-on leadership role where the individual will architect Eko’s reimbursement presence from the ground-up. This individual will build coverage and payment models for a new category of medical technology across commercial payors and Medicare, defining Eko’s value story, building clinical and economic dossiers to support the narrative, leading Eko’s first interactions with payors, equipping Eko’s sales team with the information they need to be successful, establishing the infrastructure necessary for successful claims and reimbursement, and being the “voice of the payor” in strategic, technological, and clinical discussions across the company.
The ideal candidate has built favorable reimbursement conditions for innovative, first-in-category medical devices and can excel in strategic, operational, internal, and external environments.
Eko is elevating the way clinicians detect and monitor cardiac and respiratory disease by bringing together advanced sensors, patient and provider software, and AI-powered analysis. Its FDA cleared platform is used by tens of thousands of clinicians treating millions of patients around the world, in-person, and through telehealth. The company is headquartered in Oakland, California and privately-held, with investments from ARTIS Ventures, NTT Venture Capital, DigiTx Ventures, Mayo Clinic, Sutter Health and others.
Eko is proud to be an equal opportunity employer and welcome people of different backgrounds, experiences, abilities and perspectives. We celebrate diversity and are committed to building a diverse and inclusive team.